“The Rising Adoption of Co-Processed Excipients”
- Co-processed excipients combine multiple excipients to improve flowability, compressibility, and stability, enhancing drug formulation efficiency.
- The pharmaceutical sector increasingly seeks multifunctional excipients to streamline manufacturing processes and improve product performance.
- The popularity of tablets and capsules boosts demand for co-processed excipients that facilitate better taste masking and bioavailability.
- As generic drug manufacturing expands, co-processed excipients help maintain consistent quality and efficacy across products
- For instance, Roquette launched PEARLITOL Flash, a co-processed excipient based on mannitol (a sugar alcohol) and starch for fast-dissolving tablets, improving patient compliance and product performance.
- The integration of co-processed excipients addresses multiple formulation challenges, positioning them as a key driver in the evolution of sugar-based excipients within the pharmaceutical industry.
